Thursday, November 07, 2024 10:32:45 AM
....."Since no currently approved ophthalmic formulations of bevacizumab are available, clinicians wishing to treat retinal patients with bevacizumab have had to use unapproved repackaged IV bevacizumab provided by compounding pharmacies, products that have risk of contamination and inconsistent potency and availability. If approved, ONS-5010 will replace the need to use unapproved repackaged IV bevacizumab from compounding pharmacies for the treatment of wet AMD. We currently intend to commercialize ONS-5010 in both vial and pre-filled syringe formulations....""
......
Recent OTLK News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2025 10:16:07 PM
- Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial • GlobeNewswire Inc. • 01/16/2025 11:00:00 AM
- Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment • GlobeNewswire Inc. • 01/08/2025 02:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/27/2024 09:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2024 01:14:56 PM
- Outlook Therapeutics® Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update • GlobeNewswire Inc. • 12/27/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2024 09:11:28 PM
- Outlook Therapeutics® Streamlines Operations • GlobeNewswire Inc. • 12/13/2024 09:30:00 PM
- Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD • GlobeNewswire Inc. • 12/04/2024 01:05:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2024 12:27:55 PM
- Outlook Therapeutics® Announces Executive Leadership Transition • GlobeNewswire Inc. • 12/03/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2024 05:26:46 PM
- Outlook Therapeutics® Announces Preliminary Topline Results of NORSE EIGHT Clinical Trial • GlobeNewswire Inc. • 11/27/2024 11:50:00 AM
- Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference • GlobeNewswire Inc. • 11/06/2024 01:05:00 PM
- Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment • GlobeNewswire Inc. • 10/17/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 12:30:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 12:30:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 12:30:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 12:30:09 AM
- Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series • GlobeNewswire Inc. • 09/16/2024 12:05:00 PM
- Outlook Therapeutics® Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series • GlobeNewswire Inc. • 09/13/2024 01:05:00 PM
- Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial • GlobeNewswire Inc. • 09/04/2024 12:35:00 PM
- Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 12:45:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/14/2024 08:55:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:15:28 PM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM
UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM
HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM
Zefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects • ZEFI • Jan 15, 2025 7:33 AM